K Cooper

Summary

Affiliation: University of Southampton
Country: UK

Publications

  1. pmc An economic model of school-based behavioral interventions to prevent sexually transmitted infections
    Keith Cooper
    Southampton Health Technology Assessments Centre SHTAC, University of Southampton, Southampton, UK
    Int J Technol Assess Health Care 28:407-14. 2012
  2. ncbi A review of health care models for coronary heart disease interventions
    K Cooper
    Wessex Institute for Health Research and Development, University of Southampton, Highfield, Southampton, Hants S016 7PX, UK
    Health Care Manag Sci 9:311-24. 2006
  3. doi A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations
    K Cooper
    Southampton Health Technology Assessments Centre, Boldrewood, University of Southampton, Southampton, SO16 7PX
    QJM 101:631-41. 2008
  4. doi Adalimumab for the treatment of psoriasis
    D Turner
    Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK
    Health Technol Assess 13:49-54. 2009
  5. doi Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation
    E Loveman
    Southampton Health Technology Assessments Centre SHTAC, University of Southampton, Southampton, UK
    Health Technol Assess 16:iii-xiii, 1-137. 2012
  6. doi The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
    J Picot
    Southampton Health Technology Assessments Centre, Southampton, UK
    Health Technol Assess 15:1-204. 2011
  7. doi Ustekinumab for the treatment of moderate to severe psoriasis
    E Gospodarevskaya
    Southampton Health Technology Assessments Centre, University of Southampton, UK
    Health Technol Assess 13:61-6. 2009
  8. doi Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation
    J Bryant
    Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
    Health Technol Assess 13:iii, ix-xi, 1-126. 2009
  9. doi Gemcitabine for the treatment of metastatic breast cancer
    J Jones
    Southampton Health Technology Assessments Centre, Southampton, UK
    Health Technol Assess 13:1-7. 2009
  10. doi Omalizumab for the treatment of severe persistent allergic asthma
    J Jones
    Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK
    Health Technol Assess 13:31-9. 2009

Collaborators

Detail Information

Publications24

  1. pmc An economic model of school-based behavioral interventions to prevent sexually transmitted infections
    Keith Cooper
    Southampton Health Technology Assessments Centre SHTAC, University of Southampton, Southampton, UK
    Int J Technol Assess Health Care 28:407-14. 2012
    ..Behavioral interventions which teach skills to practice safer sex may reduce the incidence of STIs. We evaluated the cost-effectiveness of school-based behavioral interventions in young people...
  2. ncbi A review of health care models for coronary heart disease interventions
    K Cooper
    Wessex Institute for Health Research and Development, University of Southampton, Highfield, Southampton, Hants S016 7PX, UK
    Health Care Manag Sci 9:311-24. 2006
    ..We recommend that the reporting of model structure, assumptions and input parameters is more explicit, to reduce the risk of biased reporting and ensure greater confidence in the model results...
  3. doi A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations
    K Cooper
    Southampton Health Technology Assessments Centre, Boldrewood, University of Southampton, Southampton, SO16 7PX
    QJM 101:631-41. 2008
    ..New techniques for diagnosing hereditary haemochromatosis (HHC) have become available alongside traditional tests such as liver biopsy and serum iron studies...
  4. doi Adalimumab for the treatment of psoriasis
    D Turner
    Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK
    Health Technol Assess 13:49-54. 2009
    ....
  5. doi Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation
    E Loveman
    Southampton Health Technology Assessments Centre SHTAC, University of Southampton, Southampton, UK
    Health Technol Assess 16:iii-xiii, 1-137. 2012
    ....
  6. doi The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
    J Picot
    Southampton Health Technology Assessments Centre, Southampton, UK
    Health Technol Assess 15:1-204. 2011
    ..More recently, combination therapies have incorporated drugs such as thalidomide (Thalidomide CelgeneĀ®, Celgene) and bortezomib (VelcadeĀ®, Janssen-Cilag)...
  7. doi Ustekinumab for the treatment of moderate to severe psoriasis
    E Gospodarevskaya
    Southampton Health Technology Assessments Centre, University of Southampton, UK
    Health Technol Assess 13:61-6. 2009
    ..Provisional NICE guidance issued as a result of the STA states that ustekinumab is recommended as a treatment option for adults with plaque psoriasis when a number of criteria are met. Final guidance is anticipated in September 2009...
  8. doi Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation
    J Bryant
    Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
    Health Technol Assess 13:iii, ix-xi, 1-126. 2009
    ..To evaluate DNA testing for detecting hereditary haemochromatosis (HHC) in subgroups of patients suspected of having the disorder and in family members of those diagnosed with HHC...
  9. doi Gemcitabine for the treatment of metastatic breast cancer
    J Jones
    Southampton Health Technology Assessments Centre, Southampton, UK
    Health Technol Assess 13:1-7. 2009
    ....
  10. doi Omalizumab for the treatment of severe persistent allergic asthma
    J Jones
    Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK
    Health Technol Assess 13:31-9. 2009
    ..It should be prescribed by a doctor who is experienced in asthma and allergy medicine at a specialist centre. If omalizumab does not control the asthma after 16 weeks, treatment should be stopped...
  11. doi The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review
    E Loveman
    Southampton Health Technology Assessments Centre, UK
    Health Technol Assess 15:1-182. 2011
    ..To assess the long-term clinical effectiveness and cost-effectiveness of multicomponent weight management schemes for adults in terms of weight loss and maintenance of weight loss...
  12. doi The effectiveness and cost-effectiveness of behavioural interventions for the prevention of sexually transmitted infections in young people aged 13-19: a systematic review and economic evaluation
    J Shepherd
    Southampton Health Technology Assessments Centre, UK
    Health Technol Assess 14:1-206, iii-iv. 2010
    ....
  13. doi A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations
    J Bryant
    Southampton Health Technology Assessments Centre, Mailpoint 728, Boldrewood, University of Southampton, Southampton SO167PX, UK
    J Med Genet 45:513-8. 2008
    ..To evaluate the clinical validity and clinical utility of DNA testing in people suspected of having hereditary haemochromatosis and in family members of those diagnosed with the disorder...
  14. doi Are educational interventions to prevent catheter-related bloodstream infections in intensive care unit cost-effective?
    K Cooper
    Southampton Health Technology Assessments Centre, University of Southampton, Southampton, UK Electronic address
    J Hosp Infect 86:47-52. 2014
    ..It is unclear how effective these are at reducing the risk of bloodstream infections from the use of intravascular catheters (catheter-BSIs) and the associated costs and health benefits...
  15. doi Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation
    A Takeda
    Southampton Health Technology Assessments Centre, Southampton, UK
    Health Technol Assess 14:1-209, iii-iv. 2010
    ....
  16. doi Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
    J Jones
    Southampton Health Technology Assessments Centre, Wessex Institute, University of Southampton, Southampton, UK
    Health Technol Assess 14:23-9. 2010
    ....
  17. doi Clinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): a systematic review and economic evaluation
    J Shepherd
    Southampton Health Technology Assessments Centre SHTAC, University of Southampton, Southampton, UK
    Health Technol Assess 17:1-264. 2013
    ..This may also prolong recovery times, potentially increasing health-care costs. If anaesthesia is too light, patients may not be fully unconscious and could be at risk of intraoperative awareness...
  18. doi Entecavir for the treatment of chronic hepatitis B infection
    J Shepherd
    Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
    Health Technol Assess 13:31-6. 2009
    ....
  19. doi Telbivudine for the treatment of chronic hepatitis B infection
    D Hartwell
    Southampton Health Technology Assessments Centre, University of Southampton, First Floor, Epsilon House, Enterprise Road, Southampton Science Park, Southampton, UK
    Health Technol Assess 13:23-30. 2009
    ....
  20. doi Bortezomib for the treatment of multiple myeloma patients
    C Green
    Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
    Health Technol Assess 13:29-33. 2009
    ....
  21. doi Infliximab for the treatment of adults with psoriasis
    E Loveman
    Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
    Health Technol Assess 13:55-60. 2009
    ..In addition, when using the Dermatology Life Quality Index (DLQI), care should be taken to take into account the patient's disabilities, to ensure DLQI continues to be an accurate measure...
  22. ncbi The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review
    J L Colquitt
    Southampton Health Technology Assessments Centre, University of Southampton, UK
    Health Technol Assess 11:iii-iv, ix-xi, 1-93. 2007
    ..To assess the clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome (SRNS)...
  23. pmc Using simulation to estimate the cost effectiveness of improving ambulance and thrombolysis response times after myocardial infarction
    D Chase
    Health Care Research Unit, University of Southampton, Southampton General Hospital, Southampton, UK
    Emerg Med J 23:67-72. 2006
    ..To quantify the health gains and costs associated with improving ambulance and thrombolysis response times for acute myocardial infarction...
  24. pmc Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations
    K Cooper
    Center for Molecular Medicine and Infectious Diseases, Virginia Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institutes and State University, 1410 Price s Fork Road, Blacksburg, VA 24061, USA
    J Clin Microbiol 43:1684-8. 2005
    ..The results indicated that genotype 1 or 2 swine HEV does not exist in pigs from countries where the respective human HEV genotype 1 or 2 is prevalent. It is likely that only genotype 3 and 4 HEV strains have zoonotic potential...